Skip to content
OpenCapital
Get started

vTv Therapeutics VTVT Q4 2024 Annual earnings

Reported March 20, 2025 · Before market open

Revenue$17.0KDiluted EPS-$0.55Beat by $0.32
EPS estimate-$0.87

Next report

Aug 11, 2026 (In 4 weeks)
Revenue estimate$333.3K
EPS estimate-$0.97

Versus estimates

Revenue

Q1 2026$36.8MBeat by $16.8M
Q4 2024$17.0K

Diluted EPS

Q1 2026$1.65Beat by $1.31Q4 2025-$0.58Beat by $0.40Q3 2025-$1.08Miss by $0.11Q2 2025-$0.92Miss by $0.07Q1 2025-$0.77Miss by $0.04
Q4 2024-$0.55Beat by $0.32

Ask the moment vTv Therapeutics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did vTv Therapeutics report Q4 2024 earnings?
vTv Therapeutics (VTVT) reported Q4 2024 earnings on March 20, 2025 before market open.
What were vTv Therapeutics's Q4 2024 revenue and EPS?
vTv Therapeutics reported revenue of $17.0K and diluted EPS of $-0.55 for Q4 2024.
Did vTv Therapeutics beat estimates in Q4 2024?
EPS beat the consensus estimate of $-0.87 by $0.32.
Where can I find vTv Therapeutics's Q4 2024 SEC filings?
You can read the 10-K periodic report (0001641489-25-000014) directly on SEC EDGAR. The filing index links above go to sec.gov.